Literature DB >> 11284721

Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.

M Hjerrild1, D Milne, N Dumaz, T Hay, O G Issinger, D Meek.   

Abstract

Murine double minute clone 2 oncoprotein (MDM2) is a key component in the regulation of the tumour suppressor p53. MDM2 mediates the ubiqutination of p53 in the capacity of an E3 ligase and targets p53 for rapid degradation by the proteasome. Stress signals which impinge on p53, leading to its activation, promote disruption of the p53-MDM2 complex, as in the case of ionizing radiation, or block MDM2 synthesis and thereby reduce cellular MDM2 levels, as in the case of UV radiation. It is therefore likely that MDM2, which is known to be modified by ubiquitination, SUMOylation and multi-site phosphorylation, may itself be a target for stress signalling (SUMO is small ubiquitin-related modifier-1). In the present study we show that, like p53, the MDM2 protein is a substrate for phosphorylation by the protein kinase CK2 (CK2) in vitro. CK2 phosphorylates a single major site, Ser(267), which lies within the central acidic domain of MDM2. Fractionation of cellular extracts revealed the presence of a single Ser(267) protein kinase which co-purified with CK2 on ion-exchange chromatography and, like CK2, was subject to inhibition by micromolar concentrations of the CK2-specific inhibitor 5,6-dichlororibofuranosylbenzimidazole. Radiolabelling of cells expressing tagged recombinant wild-type MDM2 or a S267A (Ser(267)-->Ala) mutant, followed by phosphopeptide analysis, confirmed that Ser(267) is a cellular target for phosphorylation. Ser(267) mutants are still able to direct the degradation of p53, but in a slightly reduced capacity. These data highlight a potential route by which one of several physiological modifications occurring within the central acidic domain of the MDM2 protein can occur.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284721      PMCID: PMC1221745          DOI: 10.1042/0264-6021:3550347

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  CK2: a protein kinase in need of control.

Authors:  B Guerra; B Boldyreff; S Sarno; L Cesaro; O G Issinger; L A Pinna
Journal:  Pharmacol Ther       Date:  1999 May-Jun       Impact factor: 12.310

2.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 3.  Regulation of p53 stability.

Authors:  M Ashcroft; K H Vousden
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

Review 4.  Mechanisms of switching on p53: a role for covalent modification?

Authors:  D W Meek
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

5.  Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.

Authors:  C Blattner; A Sparks; D Lane
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage.

Authors:  R Khosravi; R Maya; T Gottlieb; M Oren; Y Shiloh; D Shkedy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53.

Authors:  D Keller; X Zeng; X Li; M Kapoor; M S Iordanov; Y Taya; G Lozano; B Magun; H Lu
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

Review 8.  The p53 pathway.

Authors:  C Prives; P A Hall
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

9.  Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.

Authors:  N Dumaz; D W Meek
Journal:  EMBO J       Date:  1999-12-15       Impact factor: 11.598

10.  The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.

Authors:  D W Meek; S Simon; U Kikkawa; W Eckhart
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  12 in total

1.  Hypophosphorylation of Mdm2 augments p53 stability.

Authors:  Christine Blattner; Trevor Hay; David W Meek; David P Lane
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

2.  Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.

Authors:  Nerea Allende-Vega; Lynsey McKenzie; David Meek
Journal:  Mol Cell Biochem       Date:  2008-06-12       Impact factor: 3.396

3.  Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.

Authors:  Christopher N Batuello; Paula M Hauck; Jaimie M Gendron; Jason A Lehman; Lindsey D Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome.

Authors:  Stefan Uhle; Ohad Medalia; Richard Waldron; Renate Dumdey; Peter Henklein; Dawadschargal Bech-Otschir; Xiaohua Huang; Matthias Berse; Joseph Sperling; Rüdiger Schade; Wolfgang Dubiel
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

5.  Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

Authors:  Michael I Carr; Stephen N Jones
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

6.  Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2.

Authors:  Nerea Allende-Vega; Sylvia Dias; Diane Milne; David Meek
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

7.  Controlling the Mdm2-Mdmx-p53 Circuit.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

Review 8.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

9.  Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

Authors:  Zehavit Goldberg; Ronit Vogt Sionov; Michael Berger; Yaara Zwang; Ruth Perets; Richard A Van Etten; Moshe Oren; Yoichi Taya; Ygal Haupt
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 10.  MDM2 oligomers: antagonizers of the guardian of the genome.

Authors:  P L Leslie; Y Zhang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.